| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Science Officer
1 company
Do Hung is a Chief Science Officer at AMICUS THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $6.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Science Officer | Sell | 111,125 | $23.88 | $2,653,276.06 | -21.3% | |
| Oct 9, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Science Officer | Sale+OE | 193,700 | $15.03 | $2,911,272.26 | -27.1% | |
| Feb 12, 2020 | FOLD Amicus Therapeutics, Inc. | Chief Science Officer | Sale+OE | 63,356 | $11.01 | $697,340.49 | -11.0% | |
| Jan 16, 2019 | FOLD Amicus Therapeutics, Inc. | Chief Science Officer | Sale+OE | 53,269 | $12.03 | $641,061.45 | -5.7% | |
| Jun 1, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Science Officer | Sell | 25,000 | $16.72 | $418,000.00 | -5.9% | |
| May 16, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Science Officer | Sell | 25,000 | $15.00 | $375,000.00 | -5.6% | |
| Apr 17, 2018 | FOLD Amicus Therapeutics, Inc. | Chief Science Officer | Sell | 50,000 | $15.00 | $750,000.00 | -10.1% | |
| Oct 12, 2017 | FOLD Amicus Therapeutics, Inc. | Chief Science Officer | Sale+OE | 50,194 | $14.25 | $715,359.87 | -9.6% | |
| May 19, 2017 | FOLD Amicus Therapeutics, Inc. | Chief Science Officer | Sell | 29,914 | $8.00 | $239,312.00 | -5.9% | |
| May 15, 2017 | FOLD Amicus Therapeutics, Inc. | Chief Science Officer | Sell | 29,914 | $8.00 | $239,312.00 | -5.6% |